{"transactions":[{"id":2360014,"issuer":{"id":123059,"kind":"organization","name":"Forma Therapeutics Holdings, Inc.","symbol":"FMTX"},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T17:14:34.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on February 28, 2023, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter."}],"balance_after":37500,"derivative":{"exercise_price":9.86,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000899243-22-008644","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924322008644/doc4.xml","form_type":"4"}},{"id":2360013,"issuer":{"id":123059,"kind":"organization","name":"Forma Therapeutics Holdings, Inc.","symbol":"FMTX"},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-02T17:14:34.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock."}],"balance_after":41469,"source":{"system":"sec-edgar","filing":"0000899243-22-008644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924322008644/doc4.xml","form_type":"4"}},{"id":2371680,"issuer":{"id":123059,"kind":"organization","name":"Forma Therapeutics Holdings, Inc.","symbol":"FMTX"},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-02-25T17:09:03.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":3531,"price":9.7775,"value":34524.3525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":16469,"source":{"system":"sec-edgar","filing":"0000899243-22-007924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924322007924/doc4.xml","form_type":"4"}},{"id":2819391,"issuer":{"id":123059,"kind":"organization","name":"Forma Therapeutics Holdings, Inc.","symbol":"FMTX"},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-02T20:29:38.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":43550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on February 22, 2022,  and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter."}],"balance_after":43550,"derivative":{"exercise_price":38.61,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":43550},"source":{"system":"sec-edgar","filing":"0000899243-21-009155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924321009155/doc4.xml","form_type":"4"}},{"id":2819390,"issuer":{"id":123059,"kind":"organization","name":"Forma Therapeutics Holdings, Inc.","symbol":"FMTX"},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-02T20:29:38.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represented restricted stock units and will be settled into common stock upon vesting.  Each restricted stock unit would be converted into one share of FMTX common stock."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-21-009155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924321009155/doc4.xml","form_type":"4"}},{"id":2819389,"issuer":{"id":123059,"kind":"organization","name":"Forma Therapeutics Holdings, Inc.","symbol":"FMTX"},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-02T20:29:38.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represented restricted stock units and will be settled into common stock upon vesting.  Each restricted stock unit would be converted into one share of FMTX common stock."}],"balance_after":14300,"source":{"system":"sec-edgar","filing":"0000899243-21-009155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924321009155/doc4.xml","form_type":"4"}},{"id":3102939,"issuer":{"id":123059,"kind":"organization","name":"Forma Therapeutics Holdings, Inc.","symbol":"FMTX"},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T19:41:23.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":23378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on June 18, 2021 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":20,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":23378},"source":{"system":"sec-edgar","filing":"0000899243-20-017449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924320017449/doc4.xml","form_type":"4"}},{"id":3683673,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"RESTRICTED STOCK UNITS","published_at":"2019-01-29T18:51:02.000Z","date":"2019-01-26","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019, and 50% on January 26, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019, and 50% on January 26, 2020."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-19-002136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924319002136/doc4.xml","form_type":"4"}},{"id":3683672,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK","published_at":"2019-01-29T18:51:02.000Z","date":"2019-01-26","kind":"exercise","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":147435,"source":{"system":"sec-edgar","filing":"0000899243-19-002136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924319002136/doc4.xml","form_type":"4"}},{"id":4084714,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2018-01-30T20:58:08.000Z","date":"2018-01-30","kind":"grant","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option will vest as to 25% of the shares on January 30, 2019.  The remainder of the shares will vest in 12 equal quarterly installments thereafter."}],"balance_after":75000,"derivative":{"exercise_price":10.42,"expiration_date":"2028-01-29","underlying":"COMMON STOCK","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-18-002327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924318002327/doc4.xml","form_type":"4"}},{"id":4084713,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"RESTRICTED STOCK UNITS","published_at":"2018-01-30T20:58:08.000Z","date":"2018-01-26","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020."}],"balance_after":20000,"derivative":{"underlying":"COMMON STOCK","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-18-002327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924318002327/doc4.xml","form_type":"4"}},{"id":4084712,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK","published_at":"2018-01-30T20:58:08.000Z","date":"2018-01-26","kind":"sale","acquired":false,"shares":1738,"price":11.02,"value":19152.76,"ownership":{"direct":true},"balance_after":139935,"source":{"system":"sec-edgar","filing":"0000899243-18-002327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924318002327/doc4.xml","form_type":"4"}},{"id":4084711,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK","published_at":"2018-01-30T20:58:08.000Z","date":"2018-01-26","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":141673,"source":{"system":"sec-edgar","filing":"0000899243-18-002327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924318002327/doc4.xml","form_type":"4"}},{"id":4478998,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & EVP"}}],"security":"Restricted Stock Units","published_at":"2017-01-27T17:50:56.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest as to 20% on January 26, 2018, 30% on January 26, 2019 and 50% on January 26, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units vest as to 20% on January 26, 2018, 30% on January 26, 2019 and 50% on January 26, 2020."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-17-002119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924317002119/doc4.xml","form_type":"4"}},{"id":4478997,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":129728,"kind":"person","name":"COOK DAVID N","position":1,"cik":"0001233684","reported_name":"COOK DAVID N","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & EVP"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-27T17:50:56.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares on January 26, 2018.  The remainder of the shares will vest in 12 equal quarterly installments thereafter."}],"balance_after":75000,"derivative":{"exercise_price":9.89,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-17-002119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233684/000089924317002119/doc4.xml","form_type":"4"}}]}